Search Login Register

strontium ranelate (protelos) Summary

Description: an uncoupling agent containing strontium prevents bone loss by depressing bone resorption & maintaining bone formation in estrogen-deficient rats

Also Known As: protelos; 3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; S 12911; S-12911; S12911 Show All >>

Networked: 346 relevant articles (62 outcomes, 102 trials/studies) for this Bio-Agent

Key Diseases for which strontium ranelate is Relevant

  1. Osteoporosis : 40 outcomes 58 studies in 199 results
  2. Postmenopausal Osteoporosis : 16 outcomes 23 studies in 92 results
  3. Bone Resorption : 7 outcomes 11 studies in 84 results
  4. Osteoporotic Fractures : 6 outcomes 6 studies in 22 results
  5. Hip Fractures (Intertrochanteric Fractures) : 5 outcomes 6 studies in 19 results
Show All >>

Drugs Related to strontium ranelate

  1. Diphosphonates
  2. Strontium
  3. Hormones
  4. Silver
  5. Teriparatide (Parathar)
  6. Parathyroid Hormone (Parathormone)
  7. risedronic acid (risedronate)
  8. denosumab
  9. Selective Estrogen Receptor Modulators (SERM)
  10. 1-hydroxycholecalciferol (alfacalcidol)
Show All >>

Therapies Related to strontium ranelate

  1. Hormone Replacement Therapy (Therapy, Hormone Replacement)
  2. Subcutaneous Injections
  3. Drug Therapy (Chemotherapy)
  4. Kyphoplasty
  5. Tooth Movement
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.